Chemotherapy of gliomas
eBook - PDF

Chemotherapy of gliomas

Basic research, experiences and results

  1. 451 pages
  2. English
  3. PDF
  4. Available on iOS & Android
eBook - PDF

Chemotherapy of gliomas

Basic research, experiences and results

Book details
Table of contents
Citations

Frequently asked questions

Simply head over to the account section in settings and click on “Cancel Subscription” - it’s as simple as that. After you cancel, your membership will stay active for the remainder of the time you’ve paid for. Learn more here.
At the moment all of our mobile-responsive ePub books are available to download via the app. Most of our PDFs are also available to download and we're working on making the final remaining ones downloadable now. Learn more here.
Both plans give you full access to the library and all of Perlego’s features. The only differences are the price and subscription period: With the annual plan you’ll save around 30% compared to 12 months on the monthly plan.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes, you can access Chemotherapy of gliomas by D. Voth, P. Krauseneck, C. Langmaid, P. Glees, D. Voth, P. Krauseneck, C. Langmaid, P. Glees in PDF and/or ePUB format, as well as other popular books in Medicine & Medical Theory, Practice & Reference. We have over one million books available in our catalogue for you to explore.

Information

Publisher
De Gruyter
Year
2019
ISBN
9783110883909

Table of contents

  1. Foreword
  2. Contents
  3. I. Special and comparative pathology of the gliomas – experimental findings
  4. Classification of supratentorial gliomas
  5. Remarks on classification and "grading" (Brief communication)
  6. Problems in the histological grading of human gliomas
  7. Comparative aspects of spontaneous gliomas in animals (Brief communications)
  8. Cell-mediated immune response during progressive glioma growth
  9. Application of immunohistological techniques to the diagnosis of gliomas
  10. Flow cytometry and micronucleus formation in brain tumours
  11. Comparative impulsecytophotometric DNA investigations of glioblastomas, oligodendrogliomas and astrocytomas
  12. Repair of O<sup>6</sup>-alkylguanine in cellular DNA: significance for tumour induction and chemotherapy
  13. Escape phenomenon of glioma cells to allogenic lymphocytes and rhythmically altered protein synthesis encoded by signal transfer
  14. Microscopical investigations on cell death in experimental gliomas in rats
  15. Human glioma xenografts in nude mice: experimental model for pre-clinical chemo-radiotherapy studies
  16. Mononuclear infiltrates in human brain tumours – possible morphological equivalence of an immunological defence reaction
  17. II. General and specialised diagnostic methods for intrinsic brain tumours
  18. Correlation between grade of malignancy of gliomas and their computer tomographic density values
  19. Cerebral gliomas studied with positron emission tomography
  20. Remarks on the follow-up of cerebellar astrocytomas (Brief communication)
  21. Cerebral cysticercosis – a contribution to the differential diagnosis of supratentorial and infratentorial gliomas
  22. Measurement of intracranial pressure. Technique and indications
  23. Intracranial pressure monitoring in postoperative treatment of supratentorial and infratentorial gliomas (Brief communication)
  24. EEG, SEP and VEP examinations during the treatment of malignant gliomas
  25. CEA and TPA in plasma and cerebrospinal fluid of patients with intracranial tumours
  26. Sensitivity of human malignant brain tumours to chemotherapeutic agents as detected by the pro-assay: preliminary results of an in vivo/in vitro correlation
  27. III. Principles of operative treatment and radiation therapy
  28. Changes induced in anaplastic gliomas and brain tissue as a result of treatment
  29. Microsurgical management of gliomas
  30. Management of malignant gliomas. A ten year survey at the Neurosurgical Department of Rennes
  31. Re-operating on malignant gliomas: Indications, problems and results
  32. The Ommaya reservoir and its significance for intrathecal cytostatic treatment. Surgical aspects and complications
  33. The significance of age as a factor in the prognosis of surgically treated cerebral gliomas (Brief communication)
  34. Quality of life following microsurgical removal of glioblastomas (Brief communication)
  35. Neuropsychological studies under the therapy of malignant gliomas
  36. Quality of life in patients with malignant brain tumours
  37. Postoperative rapid course irradiation of the glioblastoma
  38. CT-stereotactic interstitial irradiation therapy of non resectable and reentrant intracranial tumour in children and adolescents
  39. Treatment of astrocymatomas grade DI and IV with high-dose irradiation and misonidazole: preliminary report
  40. Reflections on the radiation treatment of gliomas
  41. Therapeutic results in malignant gliomas with special respect to radiotherapy
  42. Pseudo-recurrence in malignant brain tumours
  43. Histological-cytological study of the effects of misonidazole and some related substances on the nervous system
  44. Local, intratumoral chemotherapy of brain gliomas in the rat, using adriamycin – a preliminary report
  45. IV. Chemotherapy: Basic principles, experiences, results and alternative procedures
  46. Principles of cancer treatment with cytostatic agents (Brief communication)
  47. Chemotherapy of malignant gliomas – present state of treatment (Brief communication)
  48. Chemotherapy of malignant supratentorial gliomas in adult: a ten-year experience of the EORTC Brain Tumour Group
  49. Characterization of human malignant brain tumour cells in vitro and comparison of three different in vitro assays to determine their sensitivity to BCNU
  50. Combined modality treatment of operated astrocytomas grade 3–4. A prospective and randomized study of misonidazole and radiotherapy with two different radiation schedules and subsequent CCNU chemotherapy
  51. Chemotherapy of gliomas in adults and of medulloblastoma in children
  52. Combined radiation and polychemotherapy (COMP) in the postoperative treatment of high-grade supratentorial gliomas
  53. Combined chemotherapy of inoperable and operable malignant gliomas
  54. Mono-treatment of malignant glioma with a derivate of nitrosourea, ACNU (first results)
  55. Retrospective study on the effect of CCNU and radiotherapy in 44 patients with malignant glioma
  56. The treatment of brain tumours and brain metastases with a combination of Ifosfamid, BCNU and radiotherapy – preliminary results (Brief communication)
  57. Intra-arterial therapy of malignant gliomas with ACNU and BCNU in combination with phénobarbital protection (preliminary results)
  58. Critical analysis of therapy in long-term surviving patients with glioblastoma multiforme
  59. Preoperative chemo- and/or radiotherapy: its possible role in the treatment of malignant brain gliomas (Brief communication)
  60. The present state of development of multistage treatment of cancer. Fundamental principles of the two-stage regional hyperthermia technique, using the "Selectotherm" procedure, as well as the heat sensitisation of cancer tissue by means of hyperglycaemia (Brief communication)
  61. Hyperthermia-radiotherapy of the gliomas – a critical report
  62. Planning, realization and evaluation of clinical trials: some statistical aspects
  63. V. Summary of the present state of chemotherapy of the supratentorial gliomas
  64. List of contributors
  65. Author's index
  66. Subject index